Top 5 Big Data VC Funds & Investors in Cayman Islands (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Shanghai Sinobioway Sunterra Biotechnology
VC Fund
|
1 | Cayman Islands | Venture - Series Unknown | Medical, Big Data, Health Care | |
|
BioAtla
VC Fund
|
1 | Cayman Islands | Series A | Medical, Big Data, Health Care | |
|
F1 BioVentures
VC Fund
|
1 | Cayman Islands | Series A, Series B | Medical, Big Data, Health Care | |
|
Sinobioway Group
VC Fund
|
1 | Canada, Cayman Islands | Series A, Private Equity, Corporate Round | Biofuel, Medical, Big Data | |
|
SunTerra Capital
VC Fund
|
1 | Cayman Islands | Series A | Medical, Big Data, Health Care | |
| Access all 7 VC funds in Cayman Islands Big Data startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Investor list
Shanghai Sinobioway Sunterra Biotechnology focuses on cutting-edge biotechnology, specifically in the field of adoptive cellular therapies. It was formed by Sinobioway Group, Sunterra Capital, and F1 Oncology for the express purpose of developing novel CAB-CAR-T therapies for solid tumor malignancies in China. SSSB's GMP cell processingfacilities in Shanghai have been developed to support clinical research through key academic collaborations.
Show more...Investment focus
- Industry: Medical, Big Data, Health Care
- Stage:Venture - Series Unknown
- Geography: Cayman Islands
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Exuma Biotech — EXUMA Biotech is a clinical-stage biotech company advancing gene vector delivery to enhance patient access to innovative cell and gene therapies.
BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform. BioAtla is a San Diego biotech company that develops novel monoclonal antibody and cell-based therapeutics using our proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated AntibodyOptimization (CIAO!) platforms. These and other proprietary technologies (protected by more than 150 issued patents and patent applications) allow them to develop novel biologics (CABs) that are better drugs in multiple ways including more selective targeting of cancer tissue and improved manufacturability. Improved selectivity for the tumor microenvironment, even when the target is also found in normal tissue, not only improves safety but also expands the universe of potential drug targets, enabling the treatment of previously untreatable cancers.
Show more...Investment focus
- Industry: Medical, Big Data, Health Care
- Stage:Series A
- Geography: Cayman Islands
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Exuma Biotech — EXUMA Biotech is a clinical-stage biotech company advancing gene vector delivery to enhance patient access to innovative cell and gene therapies.
F1 BioVentures
Show more...Investment focus
- Industry: Medical, Big Data, Health Care
- Stage:Series A, Series B
- Geography: Cayman Islands
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Exuma Biotech — EXUMA Biotech is a clinical-stage biotech company advancing gene vector delivery to enhance patient access to innovative cell and gene therapies.
Sinobioway Group is mainly engaged in bioeconomy system establishment and bio-industry development. It primarily invests in biomedicine, bioagriculture, bioenergy, bioenvironment, bioservices, biomanufacturing and biointelligence. The company has become a flagship enterprise in China’s bioindustry and has the potential to become one of the mostcompetitive corporate groups in the world.
Show more...Investment focus
- Industry: Biofuel, Medical, Big Data
- Stage:Series A, Private Equity, Corporate Round
- Geography: Canada, Cayman Islands
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Enerkem — Enerkem converts non-recyclable garbage into biofuels and renewable chemicals. Visit our website to learn more about our disruptive technology.
- Exuma Biotech — EXUMA Biotech is a clinical-stage biotech company advancing gene vector delivery to enhance patient access to innovative cell and gene therapies.
SunTerra Capital is investing in the subversive technology both at home and abroad with disruptive technology of enterprises.it promotes the commercialization of the technology in the Chinese market development, to disruptive technology investment in China and the world.
Show more...Investment focus
- Industry: Medical, Big Data, Health Care
- Stage:Series A
- Geography: Cayman Islands
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Exuma Biotech — EXUMA Biotech is a clinical-stage biotech company advancing gene vector delivery to enhance patient access to innovative cell and gene therapies.
Big Data VC funding in Cayman Islands at a glance
Stats across 4 deals from 7 investors.
Access all 7 VC funds in Cayman Islands Big Data startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Big Data VC Funds in Cayman Islands investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 7 VC funds investing in Cayman Islands Big Data startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Sign up with Google
Sign up with LinkedIn
